Varför bör vi vaccinera alla över 65 år mot influensa?

Lakartidningen

Volumn , Issue 43, 1998, Pages 4744-4748

  Linde, Annika ^a   Lindberg, Anders ^b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b Smittskyddsläkare   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGE; AGED; COST BENEFIT ANALYSIS; DRUG CONTRAINDICATION; HUMAN; INFLUENZA; MORTALITY; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; SWEDEN;

AGE FACTORS; AGED; COST-BENEFIT ANALYSIS; GUIDELINES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; RISK FACTORS; SWEDEN;

EID: 11544350241     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lindberg A, Linde A, Grandien M. Nästa influensavåg en tidsfråga. Läkartidningen 1995; 92: 3788-9.
2. Nøkleby H. Influensavaksinering en samfunnsnyttig forebygging eller stik uten effekt? Nordisk Medicin 1997; 112: 4-6.
3. Hoskins TW, Davies JR, Smith AJ, Allchin A, Miller CL, Pollock TM. Influenza at Christ's Hospital: March, 1974. Lancet 1976; 1: 105-8.
4. Fedson DS, Hannoun C, Leese J, Sprenger MJ, Hampson AW et al. Influenza vaccination in 18 developed countries, 1980-1992. Vaccine 1995; 13: 623-7.
5. Fedson DS, Hirota Y, Shin HK, Cambillard PE, Kiely J, Ambrosch F et al. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine 1997; 15: 1506-11.
6. Grandien M, Nilsson Å, Hambraeus L. Influensan och döden: Inte bara de stora epidemierna skördar många dödsoffer. Läkartidningen 1991; 88: 854-9.
7. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982; 142: 85-9.
8. Nicholson KG. Influenza vaccination and the elderly. BMJ 1990; 301: 617-8.
9. Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778-82.
10. Colquhoun AJ, Nicholson KG, Botha JL, Raymond NT. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect 1997; 119: 335-41.
11. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A metaanalysis and review of the literature. Ann Intern Med 1995; 123: 518-27.
12. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost ef-fectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778-84.
13. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661-5.
14. Gross PA, Denning CR, Gaerlan PF, Bonelli J, Bernius M, Dran S et al. Annual influenza vaccination: immune response in patients over 10 years. Vaccine 1996; 14: 1280-4.
15. Chalmers A, Scheifele D, Patterson C, Williams D, Weber J, Shuckett R,et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. J Rheumatol 1995; 21: 1203-6.
16. Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurol 1997; 48: 312-4.
17. Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M et al. The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med 1995; 333: 889-93.
18. Kumpulainen V, Makela M. Influenza vaccination among healthy employees: a cost-benefit analysis. Scand J Infect Dis 1997; 29: 181-5.
19. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997; 337: 874-80.
20. Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influensavirus vaccine in children. N Engl J Med 1998; 338: 1405-12.